200 related articles for article (PubMed ID: 35020813)
1. Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes.
Xue Y; Kossar AP; Abramov A; Frasca A; Sun M; Zyablitskaya M; Paik D; Kalfa D; Della Barbera M; Thiene G; Kozaki S; Kawashima T; Gorman JH; Gorman RC; Gillespie MJ; Carreon CK; Sanders SP; Levy RJ; Ferrari G
Cardiovasc Res; 2023 Mar; 119(1):302-315. PubMed ID: 35020813
[TBL] [Abstract][Full Text] [Related]
2. Bioprosthetic heart valve structural degeneration associated with metabolic syndrome: Mitigation with polyoxazoline modification.
Abramov A; Xue Y; Zakharchenko A; Kurade M; Soni RK; Levy RJ; Ferrari G
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2219054120. PubMed ID: 36574676
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of advanced glycation end product formation and serum protein infiltration in bioprosthetic heart valve leaflets: Investigations of anti-glycation agents and anticalcification interactions with ethanol pretreatment.
Zakharchenko A; Rock CA; Thomas TE; Keeney S; Hall EJ; Takano H; Krieger AM; Ferrari G; Levy RJ
Biomaterials; 2022 Oct; 289():121782. PubMed ID: 36099713
[TBL] [Abstract][Full Text] [Related]
4. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
[TBL] [Abstract][Full Text] [Related]
5. Poly-2-methyl-2-oxazoline-modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration.
Zakharchenko A; Xue Y; Keeney S; Rock CA; Alferiev IS; Stachelek SJ; Takano H; Thomas T; Nagaswami C; Krieger AM; Chorny M; Ferrari G; Levy RJ
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35131859
[TBL] [Abstract][Full Text] [Related]
6. Model studies of advanced glycation end product modification of heterograft biomaterials: The effects of in vitro glucose, glyoxal, and serum albumin on collagen structure and mechanical properties.
Rock CA; Keeney S; Zakharchenko A; Takano H; Spiegel DA; Krieger AM; Ferrari G; Levy RJ
Acta Biomater; 2021 Mar; 123():275-285. PubMed ID: 33444798
[TBL] [Abstract][Full Text] [Related]
7. Dual-crosslinked bioprosthetic heart valves prepared by glutaraldehyde crosslinked pericardium and poly-2-hydroxyethyl methacrylate exhibited improved antithrombogenicity and anticalcification properties.
Huang X; Zheng C; Ding K; Zhang S; Lei Y; Wei Q; Yang L; Wang Y
Acta Biomater; 2022 Dec; 154():244-258. PubMed ID: 36306983
[TBL] [Abstract][Full Text] [Related]
8. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties.
Yu T; Pu H; Chen X; Kong Q; Chen C; Li G; Jiang Q; Wang Y
Acta Biomater; 2023 Apr; 160():45-58. PubMed ID: 36764592
[TBL] [Abstract][Full Text] [Related]
9. Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction.
Lee S; Levy RJ; Christian AJ; Hazen SL; Frick NE; Lai EK; Grau JB; Bavaria JE; Ferrari G
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28483776
[TBL] [Abstract][Full Text] [Related]
10. Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves.
McGregor C; Byrne G; Rahmani B; Chisari E; Kyriakopoulou K; Burriesci G
Acta Biomater; 2016 Sep; 41():204-209. PubMed ID: 27268480
[TBL] [Abstract][Full Text] [Related]
11. A PEGylation method of fabricating bioprosthetic heart valves based on glutaraldehyde and 2-amino-4-pentenoic acid co-crosslinking with improved antithrombogenicity and cytocompatibility.
Ding K; Zheng C; Huang X; Zhang S; Li M; Lei Y; Wang Y
Acta Biomater; 2022 May; 144():279-291. PubMed ID: 35365404
[TBL] [Abstract][Full Text] [Related]
12. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
[TBL] [Abstract][Full Text] [Related]
13. Degeneration of Bioprosthetic Heart Valves: Update 2020.
Kostyunin AE; Yuzhalin AE; Rezvova MA; Ovcharenko EA; Glushkova TV; Kutikhin AG
J Am Heart Assoc; 2020 Oct; 9(19):e018506. PubMed ID: 32954917
[TBL] [Abstract][Full Text] [Related]
14. Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration.
Marro M; Kossar AP; Xue Y; Frasca A; Levy RJ; Ferrari G
J Am Heart Assoc; 2021 Feb; 10(3):e018921. PubMed ID: 33494616
[TBL] [Abstract][Full Text] [Related]
15. Studying Xenograft Rejection of Bioprosthetic Heart Valves.
Manji RA; Manji JS
Methods Mol Biol; 2020; 2110():227-243. PubMed ID: 32002912
[TBL] [Abstract][Full Text] [Related]
16. Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification.
Connolly JM; Bakay MA; Alferiev IS; Gorman RC; Gorman JH; Kruth HS; Ashworth PE; Kutty JK; Schoen FJ; Bianco RW; Levy RJ
Ann Thorac Surg; 2011 Sep; 92(3):858-65. PubMed ID: 21871270
[TBL] [Abstract][Full Text] [Related]
17. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
[TBL] [Abstract][Full Text] [Related]
18. Biological Equivalence of GGTA-1 Glycosyltransferase Knockout and Standard Porcine Pericardial Tissue Using 90-Day Mitral Valve Implantation in Adolescent Sheep.
McGregor C; Salmonsmith J; Burriesci G; Byrne G
Cardiovasc Eng Technol; 2022 Jun; 13(3):363-372. PubMed ID: 34820778
[TBL] [Abstract][Full Text] [Related]
19. A synergistic strategy of dual-crosslinking and loading intelligent nanogels for enhancing anti-coagulation, pro-endothelialization and anti-calcification properties in bioprosthetic heart valves.
Hu M; Shi S; Peng X; Pu X; Yu X
Acta Biomater; 2023 Nov; 171():466-481. PubMed ID: 37793601
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure.
Kostyunin AE; Glushkova TV; Lobov AA; Ovcharenko EA; Zainullina BR; Bogdanov LA; Shishkova DK; Markova VE; Asanov MA; Mukhamadiyarov RA; Velikanova EA; Akentyeva TN; Rezvova MA; Stasev AN; Evtushenko AV; Barbarash LS; Kutikhin AG
J Am Heart Assoc; 2023 Jan; 12(1):e028215. PubMed ID: 36565196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
